Roche Holding AG (OTCMKTS:RHHBY) Position Lessened by Hancock Whitney Corp

Hancock Whitney Corp lowered its position in Roche Holding AG (OTCMKTS:RHHBY) by 19.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,487 shares of the company’s stock after selling 5,508 shares during the quarter. Hancock Whitney Corp’s holdings in Roche were worth $814,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Cardinal Capital Management Inc. acquired a new stake in shares of Roche in the 2nd quarter valued at $16,860,000. Saratoga Research & Investment Management boosted its stake in shares of Roche by 6.9% during the 1st quarter. Saratoga Research & Investment Management now owns 2,458,918 shares of the company’s stock worth $78,489,000 after acquiring an additional 158,482 shares in the last quarter. Meritage Portfolio Management increased its holdings in shares of Roche by 186.9% during the 1st quarter. Meritage Portfolio Management now owns 174,714 shares of the company’s stock valued at $5,577,000 after acquiring an additional 113,823 shares during the last quarter. Hantz Financial Services Inc. bought a new position in shares of Roche in the 2nd quarter valued at approximately $1,164,000. Finally, ORG Partners LLC acquired a new stake in Roche in the 1st quarter worth approximately $689,000.

Analyst Ratings Changes

A number of research analysts have weighed in on RHHBY shares. The Goldman Sachs Group began coverage on shares of Roche in a research report on Thursday, May 30th. They set a “sell” rating for the company. Bank of America upgraded Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Finally, Deutsche Bank Aktiengesellschaft downgraded Roche from a “hold” rating to a “sell” rating in a research report on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, Roche presently has a consensus rating of “Hold”.

Roche Stock Performance

OTCMKTS:RHHBY opened at $39.45 on Monday. The firm’s 50-day moving average is $40.05 and its 200-day moving average is $35.07. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.04 and a current ratio of 1.35. Roche Holding AG has a 52-week low of $29.20 and a 52-week high of $42.43.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.